|
|
|
|
The Renin Angiotensin System: ACE Inhibition
|
|
|
|
The Renin Angiotensin System: AT1 Blockade
|
|
|
|
RAAS Blockade Across the CV Continuum
|
|
|
|
2007 ESH/ESC Guidelines
|
|
|
|
Effect of Different Antihypertensives on Incident Diabetes
|
|
|
|
|
|
Quality of Life and Antihypertensive Treatment
|
|
|
|
Persistence with Antihypertensive Therapy
|
|
|
|
ACEIs vs ARBs: Risk of Stroke
|
|
|
|
ACEIs vs ARBs: Risk of Myocardial Infarction
|
|
|
|
Antihypertensive Therapy & Type 2 Diabetes
|
|
|
|
AT1 Receptor Blockers in Type 2 Diabetes
|
|
|
|
Comparison of Enalapril & Candesartan Cilexetil:
|
|
|
|
Chemical Structures of Angiotensin II Receptor Blockers
|
|
|
|
|
Insurmountable and Surmountable Antagonism
|
|
|
|
Number of AT1-Receptor Binding Sites
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Potential Benefits of Additional BP Reductions
|
|
|
|
The Cardiovascular Continuum
|
|
|
|
Conclusions
|
|
presentation (PPTX 1.2MB)
Share this page with your colleagues and friends: